What are examples of antibiotic eye drops for treating bacterial eye infections?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Antibiotic Eye Drop Examples

For bacterial conjunctivitis, use moxifloxacin 0.5% or gatifloxacin 0.5% as first-line agents, as these fourth-generation fluoroquinolones provide superior gram-positive coverage compared to older fluoroquinolones. 1, 2, 3

FDA-Approved Fluoroquinolones

Fourth-Generation (Preferred)

  • Moxifloxacin 0.5% - Instill one drop in the affected eye 3 times daily for 7 days 2
  • Gatifloxacin 0.5% - Day 1: one drop every 2 hours while awake (up to 8 times); Days 2-7: one drop 2-4 times daily 3
  • Both agents demonstrate better gram-positive pathogen coverage than earlier generation fluoroquinolones in head-to-head in vitro studies 4, 1

Earlier Generation Options

  • Levofloxacin 1.5% - FDA-approved with equal efficacy to ofloxacin 0.3% 4
  • Ciprofloxacin 0.3% - FDA-approved for bacterial keratitis 4
  • Ofloxacin 0.3% - FDA-approved for bacterial keratitis 4

Severe Infections or Treatment Failures

For Suspected MRSA

  • Vancomycin (fortified) - Fluoroquinolones are generally poorly effective against MRSA ocular isolates, with methicillin resistance found in 42% of staphylococcal isolates 4, 1, 5
  • Topical linezolid can be used for vancomycin-resistant enterococcus 4

For Resistant Pseudomonas

  • Topical colistin 0.19% - Consider for multidrug-resistant Pseudomonas aeruginosa 4, 1
  • Note: Sharp increase in Pseudomonas resistance to moxifloxacin has been documented (19% in 2007 to 52% in 2009 in southern India) 4

Fortified Combination Therapy

  • Fortified cefazolin/tobramycin - Alternative for severe infections, especially with deep stromal involvement or infiltrates >2mm with extensive suppuration 4
  • Should be prepared by FDA-designated 503A and/or 503B compounding pharmacy 4

Special Considerations

Resistance Patterns

  • Increasing overall resistance to fluoroquinolones has been observed from 1996 to 2015 4, 5
  • Risk factors for fluoroquinolone resistance include recent fluoroquinolone use, hospitalization, and recent ocular surgery 4, 1
  • Some pathogens (Streptococci, anaerobes) have variable susceptibility to fluoroquinolones 4

Specific Pathogens

  • Gonococcal keratitis - Requires systemic antibiotic therapy in addition to topical treatment 4, 1, 5
  • Moraxella keratitis - Usually susceptible to fluoroquinolones and aminoglycosides but requires prolonged treatment duration (mean 41.9 days) 4

Common Pitfalls to Avoid

  • Do not use contact lenses during treatment if signs or symptoms of bacterial conjunctivitis are present 2, 3
  • Avoid topical corticosteroids until infection has been ruled out, as they can mask signs of infection 6
  • Prolonged use may result in overgrowth of non-susceptible organisms including fungi 2, 3
  • If no improvement after 7 days, reevaluate diagnosis and consider alternative treatment 5, 6

References

Guideline

Appropriate Eye Drop Antibiotics for Bacterial Conjunctivitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Moxifloxacin Treatment for Bacterial Conjunctivitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Antibiotic Treatment for Metal Corneal Abrasion

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.